Fermenta Biotech submits investor presentation

18 Nov 2019 Evaluate

Further to intimation dated November 13, 2019 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2019, Fermenta Biotech has informed about submission of a copy of Investor Presentation for November 2019. The said Investor Presentation is also available on Company’s website www.dil.net. 

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

172.95 -0.20 (-0.12%)
30-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1502.30
Dr. Reddys Lab 6198.90
Cipla 1402.20
Zydus Lifesciences 957.00
Lupin 1645.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.